{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Homework of week 2"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**本周作业内容如下：**\n",
    "\n",
    "    （1）Using your private domain data (for example, a set of research papers, a set of financial report documents, ...)\n",
    "    （2）Write a python program to answer questions about your data\n",
    "    • Receive question from console and generate responses in streaming way\n",
    "    • Using OpenAI SDK (or Anthropic)\n",
    "    （3）Refer to the examples in\n",
    "    https://github.com/hzeng-otterai/chatbot-example/tree/main/backend_api\n",
    "\n",
    "作业文件夹：\n",
    "https://drive.google.com/drive/u/0/folders/1Xod8qKWVxqa5aW12g7pULK8fGJzpcjCW"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "vscode": {
     "languageId": "latex"
    }
   },
   "source": [
    "**Summary of Homework of Week 2**\n",
    "\n",
    "This Jupyter Notebook is focused on extracting text from PDF files and using an AI assistant to answer finance-related questions about Bayer. \n",
    "\n",
    "The notebook demonstrates how to integrate PDF text extraction with an AI assistant to provide detailed responses to finance-related queries.\n",
    "\n",
    "    Define a system prompt template for the AI assistant, Bobby, to answer finance-related questions about Bayer.\n",
    "    Read the extracted text files (excluding specific reports) and compile the content into a single context.\n",
    "    Define asynchronous functions chat_func() and continous_chat() to handle user interactions with the AI assistant.\n",
    "    Run the continuous chat function to allow user input and AI responses in a loop.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from openai import OpenAI\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "# Specify the path to the .env file\n",
    "dotenv_path = '../.env'\n",
    "\n",
    "# Load environment variables from the specified .env file\n",
    "load_dotenv(dotenv_path)\n",
    "\n",
    "# Get the API key\n",
    "openai_api_key = os.getenv('OPENAI_API_KEY')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Python version: 3.9.7 (default, Sep 16 2021, 08:50:36) \n",
      "[Clang 10.0.0 ]\n",
      "OpenAI version: 1.59.7\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "import openai\n",
    "\n",
    "print(\"Python version:\", sys.version)\n",
    "print(\"OpenAI version:\", openai.__version__)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import glob\n",
    "import PyPDF2\n",
    "\n",
    "# extract the text from the multiple pdf files under files/bayer_finance, and save to txt files under files/bayer_finance.txt\n",
    "def extract_text_from_pdf():\n",
    "    context_files = glob.glob(\"../files/bayer_finance/*.pdf\")\n",
    "    for file_path in context_files:\n",
    "        with open(file_path, 'rb') as file:\n",
    "            reader = PyPDF2.PdfReader(file)\n",
    "            text = \"\"\n",
    "            for page_num in range(len(reader.pages)):\n",
    "                page = reader.pages[page_num]\n",
    "                text += page.extract_text() + \"\\n\"\n",
    "            txt_file_path = file_path.replace('.pdf', '.txt')\n",
    "            with open(txt_file_path, 'w') as txt_file:\n",
    "                txt_file.write(text)\n",
    "\n",
    "extract_text_from_pdf()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "User: hello\n",
      "Hello! How can I assist you today with your finance questions about Bayer?\n",
      "\n",
      "User: who are you\n",
      "I am Bobby, a virtual assistant created by Junjie. I'm here to help you with finance-related questions about Bayer. How can I assist you today?\n",
      "\n",
      "User: How about the finance condictions of Bayer\n",
      "As of the latest available information from Q3 2024, Bayer's financial conditions can be summarized as follows:\n",
      "\n",
      "1. **Sales**: Bayer reported sales of €9.968 billion in Q3 2024, which is a decline of 3.6% compared to €10.342 billion in Q3 2023. The decline was attributed to challenges in the Crop Science division, particularly due to lower sales of glyphosate-based herbicides and reduced corn acreage in Latin America.\n",
      "\n",
      "2. **EBITDA**: The EBITDA before special items decreased by 25.8% to €1.251 billion in Q3 2024, down from €1.685 billion in Q3 2023. This decline was influenced by negative currency effects and a short-term incentive (STI) effect.\n",
      "\n",
      "3. **Net Income**: Bayer reported a net income of minus €4.183 billion in Q3 2024, which was impacted by significant impairment losses in the Crop Science division.\n",
      "\n",
      "4. **Free Cash Flow**: Free cash flow for Q3 2024 was €1.148 billion, a decrease from €1.626 billion in the same quarter of the previous year.\n",
      "\n",
      "5. **Debt**: Bayer's net\n",
      "\n",
      "User: what is the biggest challenge for the company\n",
      "The biggest challenges for Bayer as of Q3 2024 include:\n",
      "\n",
      "1. **Regulatory Pressures**: Bayer faces significant regulatory challenges, particularly in its Crop Science division. This includes uncertainty surrounding the registration of key products like Dicamba and Movento, which could impact their ability to market these products effectively.\n",
      "\n",
      "2. **Litigation Issues**: Bayer continues to deal with ongoing litigation related to glyphosate and other products, which has resulted in substantial legal costs and settlements. The company has a large number of outstanding glyphosate cases, which adds to its financial uncertainty.\n",
      "\n",
      "3. **Market Conditions**: The agricultural market is experiencing headwinds, including lower commodity prices and increased generic pricing pressure in Crop Protection. These factors have led to a decline in sales and profitability in the Crop Science division.\n",
      "\n",
      "4. **Generic Competition**: Bayer's Pharmaceuticals division is facing increasing competition from generic drugs, particularly with the loss of exclusivity for products like Xarelto, which has led to significant sales declines.\n",
      "\n",
      "5. **Inflation and Cost Pressures**: Rising costs for raw materials and inflationary pressures have impacted Bayer's margins, making it challenging to maintain profitability while also investing in innovation and growth.\n",
      "\n",
      "Overall, these challenges require Bayer to navigate a complex landscape of regulatory\n",
      "\n",
      "User: for the ongoing litigation issues, how much should the company pay?\n",
      "The exact amount Bayer may need to pay for ongoing litigation issues, particularly related to glyphosate, is uncertain and can vary significantly based on the outcomes of individual cases, settlements, and other legal developments. As of the latest information, Bayer has faced approximately 177,000 claims related to glyphosate, with about 114,000 claims already settled or deemed ineligible for various reasons.\n",
      "\n",
      "In Q3 2024, Bayer reported net outflows of €189 million related to glyphosate litigation payments. However, the total potential liability can fluctuate based on trial outcomes, appeals, and any new claims that may arise. Additionally, the company is exploring various avenues to contain these litigation risks, including appealing certain cases to higher courts.\n",
      "\n",
      "Given the complexity and variability of legal proceedings, it's difficult to predict a specific total amount Bayer might ultimately pay in relation to these litigation issues. The company's financial reports and updates will provide more precise figures as they arise.\n",
      "\n",
      "User: How the DSO going?\n",
      "Bayer's Dynamic Shared Ownership (DSO) initiative is designed to create a more agile and efficient organizational structure. As of Q3 2024, the company reported significant progress in implementing DSO across its operations. Here are some key points regarding the DSO initiative:\n",
      "\n",
      "1. **Implementation Progress**: Bayer has scaled the DSO model to encompass a large portion of its organization, with approximately 80% of the workforce activated under this new operating model. This transition has led to the elimination of around 5,500 jobs, primarily in managerial positions.\n",
      "\n",
      "2. **Operational Efficiency**: The DSO initiative aims to improve operational efficiency by empowering cross-functional teams to make decisions and respond quickly to customer needs. This has resulted in faster innovation cycles and a leaner organizational structure.\n",
      "\n",
      "3. **Cost Savings**: Bayer anticipates that the DSO model will contribute to significant cost savings, with a target of achieving €2 billion in sustainable organizational savings by the end of 2026. The company is focused on optimizing its cost structure while enhancing cash generation.\n",
      "\n",
      "4. **Focus on Customer Centricity**: By adopting DSO, Bayer aims to enhance its customer focus and improve service delivery. This model allows for greater autonomy and accountability at the team level, enabling\n",
      "\n",
      "User: will there be job cutoffs in the year of 2025?\n",
      "As of the latest information available, Bayer has already implemented significant job cuts as part of its Dynamic Shared Ownership (DSO) initiative, resulting in the elimination of approximately 5,500 positions, primarily in managerial roles. While the company has not explicitly stated plans for additional job cuts in 2025, the ongoing need for operational efficiency and cost management may lead to further adjustments depending on market conditions and business performance.\n",
      "\n",
      "Bayer's leadership has indicated a focus on improving cash generation and optimizing costs, which could potentially involve reevaluating staffing needs. However, any specific decisions regarding job cuts in 2025 would likely depend on the company's performance, the success of the DSO initiative, and the overall economic environment.\n",
      "\n",
      "For the most accurate and up-to-date information, it would be best to monitor Bayer's official communications and financial reports as they approach the end of 2024 and into 2025.\n",
      "\n",
      "User: how about the outlook for 2025?\n",
      "The outlook for Bayer in 2025 is cautious, based on the latest available information. Here are some key points regarding the expected performance and challenges for that year:\n",
      "\n",
      "1. **Market Environment**: Bayer anticipates a muted outlook for the agricultural market, with expectations of continued challenges in Crop Science due to prolonged soft commodity prices and regulatory pressures. The company is preparing for potential impacts from regulatory developments, particularly concerning the registration of key products like Dicamba.\n",
      "\n",
      "2. **Pharmaceuticals Performance**: In the Pharmaceuticals division, Bayer expects continued strong growth momentum from its launch products, such as Nubeqa and Kerendia. However, the company is also preparing for increased generic competition, particularly for Xarelto, which is likely to exert downward pressure on sales and margins.\n",
      "\n",
      "3. **Consumer Health**: Bayer expects market growth in the Consumer Health division to be in line with the overall market, with a focus on driving robust growth through volume increases and efficient resource allocation.\n",
      "\n",
      "4. **Financial Targets**: Bayer has indicated that it is committed to achieving its sales growth, core earnings per share, and free cash flow targets for 2024, which will set the stage for 2025. However, the company has acknowledged that earnings may decline due to ongoing pressures in\n",
      "\n",
      "User: in summary, the outlook is positive, or negative. \n",
      "The outlook for Bayer in 2025 is mixed but leans towards cautious or negative due to several challenges. Here’s a summary:\n",
      "\n",
      "- **Negative Aspects**:\n",
      "  - **Regulatory Challenges**: Ongoing regulatory pressures, particularly concerning product registrations, could negatively impact the Crop Science division.\n",
      "  - **Generic Competition**: Increased competition from generics, especially for Xarelto, is expected to lead to declining sales and margin pressures in the Pharmaceuticals division.\n",
      "  - **Market Conditions**: A muted agricultural market outlook and prolonged soft commodity prices may hinder growth in Crop Science.\n",
      "\n",
      "- **Positive Aspects**:\n",
      "  - **Innovation in Pharmaceuticals**: Continued growth momentum from launch products like Nubeqa and Kerendia may provide some offsetting growth.\n",
      "  - **Consumer Health**: The Consumer Health division is expected to achieve moderate growth, supported by strong brand performance.\n",
      "\n",
      "Overall, while there are some positive elements, the challenges and uncertainties suggest a cautious outlook for Bayer in 2025.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "from openai import AsyncOpenAI\n",
    "import asyncio\n",
    "from datetime import datetime\n",
    "import nest_asyncio\n",
    "\n",
    "\n",
    "\n",
    "nest_asyncio.apply()\n",
    "\n",
    "client = AsyncOpenAI()\n",
    "\n",
    "# Construct the system prompt\n",
    "system_prompt_template = \"\"\"You are Bobby, a virtual assistant create by Junjie. \n",
    "Today is {today}. You provide responses to the finance questions about Bayer.\n",
    "Please answer each question truthfully to \n",
    "the best of your abilities based on the provided information. \n",
    "If you are unsure of an answer, please state that you are unsure.\n",
    "...\n",
    "\n",
    "<context>\n",
    "{context}\n",
    "</context>\n",
    "\"\"\"\n",
    "\n",
    "\n",
    "context_files = glob.glob(\"../files/bayer_finance/*.txt\")\n",
    "context_files = [file for file in context_files if not file.endswith(('bayer-annual-report-2023.txt', 'bayer-quarterly-statement-q1-2024.txt'))]\n",
    "# print(context_files)\n",
    "context_content = \"\"\n",
    "\n",
    "for file_path in context_files:\n",
    "    with open(file_path, 'r') as file:\n",
    "        context_content += file.read() + \"\\n\"\n",
    "\n",
    "with open(\"final_context.txt\", \"w\") as context_file:\n",
    "    context_file.write(context_content)\n",
    "\n",
    "system_prompt = system_prompt_template.format(\n",
    "    context=context_content, \n",
    "    today=datetime.today().strftime('%Y-%m-%d')\n",
    ")\n",
    "\n",
    "async def chat_func(history):\n",
    "\n",
    "    result = await client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=[{\"role\": \"system\", \"content\": system_prompt}] + history,\n",
    "        max_tokens=256,\n",
    "        temperature=0.5,\n",
    "        stream=True,\n",
    "    )\n",
    "\n",
    "    buffer = \"\"\n",
    "    async for r in result:\n",
    "        next_token = r.choices[0].delta.content\n",
    "        if next_token:\n",
    "            print(next_token, flush=True, end=\"\")\n",
    "            buffer += next_token\n",
    "\n",
    "    print(\"\\n\", flush=True)\n",
    "\n",
    "    return buffer\n",
    "\n",
    "async def continous_chat():\n",
    "    history = []\n",
    "\n",
    "    # Loop to receive user input continously\n",
    "    while(True):\n",
    "        user_input = input(\"> \")\n",
    "        if user_input == \"exit\":\n",
    "            break\n",
    "\n",
    "        print(f\"User: {user_input}\")\n",
    "        history.append({\"role\": \"user\", \"content\": user_input})\n",
    "\n",
    "        # notice every time we call the chat function\n",
    "        # we pass all the history to the API\n",
    "        bot_response = await chat_func(history)\n",
    "\n",
    "        history.append({\"role\": \"assistant\", \"content\": bot_response})\n",
    "\n",
    "asyncio.run(continous_chat())\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
